Old Web
English
Sign In
Acemap
>
authorDetail
>
David Wright
David Wright
AstraZeneca
Econometrics
Mathematics
Clinical trial
Estimand
Coronavirus disease 2019
5
Papers
60
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Why ITT analysis is not always the answer for estimating treatment effects in clinical trials.
2021
Contemporary Clinical Trials
Oliver N. Keene
David Wright
Alan Phillips
Melanie Wright
Show All
Source
Cite
Save
Citations (0)
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD
2020
Pharmaceutical Statistics
Oliver N. Keene
Stephen J. Ruberg
Alexander Schacht
Mouna Akacha
Rachael Lawrance
Anna Berglind
David Wright
Show All
Source
Cite
Save
Citations (6)
Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic
2020
Statistics in Biopharmaceutical Research
R. Daniel Meyer
Bohdana Ratitch
Marcel Wolbers
Olga Marchenko
Hui Quan
Daniel Li
Chrissie Fletcher
Xin Li
David Wright
Yue Shentu
Stefan Englert
Wei Shen
Jyotirmoy Dey
Thomas Liu
Ming Zhou
Norman Bohidar
Peng-Liang Zhao
Michael Hale
Show All
Source
Cite
Save
Citations (32)
Machine learning for clinical trials in the era of COVID-19
2020
Statistics in Biopharmaceutical Research
William R. Zame
Ioana Bica
Cong Shen
Alicia Curth
Hyun-Suk Lee
Stuart Bailey
James Weatherall
David Wright
Frank Bretz
Mihaela van der Schaar
Show All
Source
Cite
Save
Citations (16)
The attributable estimand: A new approach to account for intercurrent events.
2020
Pharmaceutical Statistics
Patrick Darken
Jack Nyberg
Shaila Ballal
David Wright
Show All
Source
Cite
Save
Citations (6)
1